Oriano Radillo1, Lorella Pascolo2, Stefano Martelossi1, Sara Dal Bo3, Alessandro Ventura1,3. 1. Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Trieste, Italy. 2. Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Trieste, Italy. lorella.pascolo@gmail.com. 3. Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Abstract
BACKGROUND: Fecal calprotectin is a noninvasive marker for bowel diseases and it is high valuable to follow disease activity in Crohn's disease (CD) and ulcerative colitis (UC). In this study, we evaluated the diagnostic performance of the recently introduced immunochromatographic assay CalFast in comparison to the well-known ELISA tests for calprotectin assay to obtain a rapid diagnosis of bowel inflammation in pediatric patients. METHODS: CalFast was tested in parallel to the classic ELISA tests CalPrest and PhiCal (gold standards for the calprotectin determination) on 148 fecal samples from pediatric subjects including 104 healthy subjects, 29 with CD, and 15 with UC. RESULTS: In this study, the sensitivity and specificity of CalFast, CalPrest, and PhiCal were 86.4%, 88.6%, and 93.2% and 86.6%, 74%, and 64.4%, respectively. The area under the curve, obtained from receiver operating characteristic analysis, indicated the lack of significant difference among all the kits used. CONCLUSION: The immunochromatographic assay demonstrated good diagnostic predictive values, comparable to those of the ELISA methods, and may represent a valid alternative in order to save operators' time. The test, in fact, has a short turnaround time and does not need a specific ELISA instrumentation.
BACKGROUND: Fecal calprotectin is a noninvasive marker for bowel diseases and it is high valuable to follow disease activity in Crohn's disease (CD) and ulcerative colitis (UC). In this study, we evaluated the diagnostic performance of the recently introduced immunochromatographic assay CalFast in comparison to the well-known ELISA tests for calprotectin assay to obtain a rapid diagnosis of bowel inflammation in pediatric patients. METHODS: CalFast was tested in parallel to the classic ELISA tests CalPrest and PhiCal (gold standards for the calprotectin determination) on 148 fecal samples from pediatric subjects including 104 healthy subjects, 29 with CD, and 15 with UC. RESULTS: In this study, the sensitivity and specificity of CalFast, CalPrest, and PhiCal were 86.4%, 88.6%, and 93.2% and 86.6%, 74%, and 64.4%, respectively. The area under the curve, obtained from receiver operating characteristic analysis, indicated the lack of significant difference among all the kits used. CONCLUSION: The immunochromatographic assay demonstrated good diagnostic predictive values, comparable to those of the ELISA methods, and may represent a valid alternative in order to save operators' time. The test, in fact, has a short turnaround time and does not need a specific ELISA instrumentation.
Authors: Jeffrey Hyams; James Markowitz; Anthony Otley; Joel Rosh; David Mack; Athos Bousvaros; Subra Kugathasan; M Pfefferkorn; Vasundhara Tolia; Jonathan Evans; William Treem; Robert Wyllie; Robert Rothbaum; J del Rosario; Aubrey Katz; Adam Mezoff; M Oliva-Hemker; Trudy Lerer; Anne Griffiths Journal: J Pediatr Gastroenterol Nutr Date: 2005-10 Impact factor: 2.839
Authors: Alain M Schoepfer; Michael Trummler; Petra Seeholzer; Dominique H Criblez; Frank Seibold Journal: Dis Colon Rectum Date: 2007-10 Impact factor: 4.585
Authors: N Waugh; E Cummins; P Royle; N-B Kandala; D Shyangdan; R Arasaradnam; C Clar; R Johnston Journal: Health Technol Assess Date: 2013-11 Impact factor: 4.014
Authors: Alain M Schoepfer; Christoph Beglinger; Alex Straumann; Ekaterina Safroneeva; Yvonne Romero; David Armstrong; Carsten Schmidt; Michael Trummler; Valérie Pittet; Stephan R Vavricka Journal: Inflamm Bowel Dis Date: 2013-02 Impact factor: 5.325
Authors: Dan Turner; Jeffrey Hyams; James Markowitz; Trudy Lerer; David R Mack; Jonathan Evans; Marian Pfefferkorn; Joel Rosh; Marsha Kay; Wallace Crandall; David Keljo; Anthony R Otley; Subra Kugathasan; Ryan Carvalho; Maria Oliva-Hemker; Christine Langton; Petar Mamula; Athos Bousvaros; Neal LeLeiko; Anne M Griffiths Journal: Inflamm Bowel Dis Date: 2009-08 Impact factor: 5.325
Authors: Paul Henderson; Aoife Casey; Sally J Lawrence; Nicholas A Kennedy; Kathleen Kingstone; Pam Rogers; Peter M Gillett; David C Wilson Journal: Am J Gastroenterol Date: 2012-02-28 Impact factor: 10.864
Authors: Ferdinando D'Amico; David T Rubin; Paulo Gustavo Kotze; Fernando Magro; Britta Siegmund; Taku Kobayashi; Pablo A Olivera; Peter Bossuyt; Lieven Pouillon; Edouard Louis; Eugeni Domènech; Subrata Ghosh; Silvio Danese; Laurent Peyrin-Biroulet Journal: United European Gastroenterol J Date: 2021-05-07 Impact factor: 4.623